VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study. Read more.

Discover how machine learning predicts successful discontinuation of renal therapy in critically ill patients with acute ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

As the year barrels toward its finish, pharmaceutical marketers and medical affairs teams find themselves faced with familiar decision: how to allocate their remaining budget for maximum impact. The ...

Companies the world over are searching for the best ways to implement AI into their systems, and according to a new report from S&P Global, budgets will continue to be driven into this area. The ...

What drew you into the field of RNA? I remember reading the first articles about non-coding RNAs right as I was starting my PhD and being amazed by the versatility of these molecules. RNAs can encode ...

Explore the latest insights into the multifaceted aspects of prostate cancer (PCa) treatment presented at the 2024 European Association of Urology (EAU) Congress in Paris, France. The session delved ...

Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts, Ian Bruce, University of Manchester, UK, and Julia Weinmann-Menke, ...